(Q34984689)

5 August 2017

1 reference

title

Resident bacterial flora and immune system (English)

1 reference

5 August 2017

Biancone L

1

1 reference

5 August 2017

Monteleone I

2

1 reference

5 August 2017

Del Vecchio Blanco G

3

1 reference

5 August 2017

Vavassori P

4

1 reference

5 August 2017

Pallone F

5

1 reference

5 August 2017

publication date

1 September 2002

1 reference

Digestive and Liver Disease

5 August 2017

published in

1 reference

5 August 2017

volume

34 Suppl 2

1 reference

5 August 2017

page(s)

S37-43

1 reference

Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Clarifying the causes of Crohn's

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Recent developments in the immunology of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Tumour-necrosis-factor antibody treatment in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Experimental models of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Crohn's disease: genetic susceptibility, bacteria, and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Antibodies to interleukin 12 abrogate established experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Electron microscopy in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Role of bacterial intimin in colonic hyperplasia and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Is there a role for antibiotics as primary therapy in Crohn's ileitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Double blind, placebo controlled trial of metronidazole in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Metronidazole plus ciprofloxacin in the treatment of active, refractory Crohn's disease: results of an open study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Controlled trial of bowel rest and nutritional support in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

Crohn's disease: maintenance of remission by diet

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

PROBIOTICS: GROWTH-PROMOTING FACTORS PRODUCED BY MICROORGANISMS.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980162-1

7 January 2021

10.1016/S1590-8658(02)80162-1

Identifiers

DOI

1 reference

5 August 2017

1 reference